Biologic therapies in severe asthma

被引：0
|
作者：
Dupin, C. [1 ]
机构：
[1] Hop Bichat Claude Bernard, AP HP, Pneumol A, 46 Rue Henri Hucard, F-75018 Paris, France
来源：
REVUE FRANCAISE D ALLERGOLOGIE | 2023年 / 63卷 / 03期
关键词：
Asthma; Severe asthma; Biologic; Biomarkers;
D O I：
10.1016/j.reval.2023.103300
中图分类号：
R392 [医学免疫学];
学科分类号：
100102 ;
摘要：
引用
收藏
页数：2
相关论文
共 50 条
  • [31] The biologic asthma response score A blueprint to address biologic failure in severe asthma?
    Rosas-Salazar, Christian
    Bacharier, Leonard B.
    [J]. ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 2024, 132 (01) : 7 - 8
  • [32] DIVERSITY OF PATIENT SUPPORT PROGRAMS FOR SEVERE ASTHMA TREATED WITH BIOLOGIC THERAPIES A SYSTEMATIC LITERATURE REVIEW
    Rabe, A. P.
    Loke, W. J.
    Heaney, L. G.
    Musat, M.
    Ho, H. Y.
    Kielar, D.
    Olinger, L.
    Morris, T.
    Shih, V. H.
    Majeed, A.
    [J]. VALUE IN HEALTH, 2022, 25 (12) : S393 - S393
  • [33] Safety of Biologic Therapies for Severe Asthma: An Analysis of Adverse Reactions Reported in the WHO Pharmacovigilance Database
    Cutroneo, P. M.
    Arzenton, E.
    Furci, F.
    Bulzomi, M.
    Caminati, M.
    Senna, G.
    Moretti, U.
    Trifiro, G.
    [J]. DRUG SAFETY, 2022, 45 (10) : 1160 - 1161
  • [34] Real-life small airway outcomes in severe asthma patients receiving biologic therapies
    Chan, Rory
    Kuo, Chris RuiWen
    Lipworth, Brian
    [J]. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICE, 2021, 9 (07): : 2907 - 2909
  • [35] Eligibility of C-BIOPRED severe asthma cohort for type-2 biologic therapies
    Deng Zhenan
    Jin Meiling
    Ou Changxing
    Jiang Wei
    Zhao Jianping
    Liu Xiaoxia
    Sun Shenghua
    Tang Huaping
    He Bei
    Cai Shaoxi
    Chen Ping
    Wu Penghui
    Liu Yujing
    Kang Jian
    Zhang Yunhui
    Huang Mao
    Xu Jinfu
    Huang Kewu
    Li Qiang
    Zhang Xiangyan
    Fu Xiuhua
    Wang Changzheng
    Shen Huahao
    Zhu Lei
    Shi Guochao
    Qiu Zhongmin
    Wen Zhongguang
    Wei Xiaoyang
    Gu Wei
    Wei Chunhua
    Wang Guangfa
    Xie Lixin
    Lin Jiangtao
    Tang Yuling
    Han Zhihai
    Chung Kian Fan
    Zhang Qingling
    Zhong Nanshan
    [J]. 中华医学杂志(英文版), 2023, 136 (02)
  • [36] Eligibility of C-BIOPRED severe asthma cohort for type-2 biologic therapies
    Deng, Zhenan
    Jin, Meiling
    Ou, Changxing
    Jiang, Wei
    Zhao, Jianping
    Liu, Xiaoxia
    Sun, Shenghua
    Tang, Huaping
    He, Bei
    Cai, Shaoxi
    Chen, Ping
    Wu, Penghui
    Liu, Yujing
    Kang, Jian
    Zhang, Yunhui
    Huang, Mao
    Xu, Jinfu
    Huang, Kewu
    Li, Qiang
    Zhang, Xiangyan
    Fu, Xiuhua
    Wang, Changzheng
    Shen, Huahao
    Zhu, Lei
    Shi, Guochao
    Qiu, Zhongmin
    Wen, Zhongguang
    Wei, Xiaoyang
    Gu, Wei
    Wei, Chunhua
    Wang, Guangfa
    Xie, Lixin
    Lin, Jiangtao
    Tang, Yuling
    Han, Zhihai
    Chung, Kian Fan
    Zhang, Qingling
    Zhong, Nanshan
    [J]. CHINESE MEDICAL JOURNAL, 2023, 136 (02) : 230 - 232
  • [37] Biologic treatment in persistent severe asthma
    Guerrero, Edurne Echevarria
    Larrauri, Ana Gomez
    Egurbide, Jone Solorzano
    Munoz, Imanol Gonzalez
    Llorente, Elena Garay
    Dorronsoro, Teresa Bretos
    Fernandez, Silvia Perez
    Pascual, Milagros Iriberri
    Malanda, Nuria Marina
    [J]. EUROPEAN RESPIRATORY JOURNAL, 2023, 62
  • [38] Biologic treatment options for severe asthma
    Hearn, Andrew P.
    Kent, Brian D.
    Jackson, David J.
    [J]. CURRENT OPINION IN IMMUNOLOGY, 2020, 66 : 151 - 160
  • [39] Cycling biologic therapy for severe asthma
    Hamada, S.
    Ogino, E.
    Yasuba, H.
    [J]. PULMONOLOGY, 2022, 28 (01): : 65 - 67
  • [40] Biologic Therapy and Severe Asthma in Children
    Russo, Daniele
    Di Filippo, Paola
    Attanasi, Marina
    Lizzi, Mauro
    Di Pillo, Sabrina
    Chiarelli, Francesco
    [J]. BIOMEDICINES, 2021, 9 (07)
12345